Ketamine Therapy, Explained Clearly
Understand treatment routes, safety questions, provider choices, costs, and what to ask before starting ketamine care.
Start with the basics, then move into safety, cost, provider questions, and care models at your own pace.
Choose the question that brought you here
What does ketamine therapy actually feel like?
Which treatment route should I understand first?
What should I ask before choosing a provider?
How do cost, safety, and follow-up fit together?
Find answers by the question you came in with
The six topics our readers research most — each card opens onto the deepest guides we have on that path.
At-Home & Telehealth
Compare telehealth ketamine to in-clinic care, what at-home sessions feel like, and how to vet remote providers.
Spravato & Esketamine
Branded Spravato vs. generic ketamine — coverage rules, dosing, and what the FDA-approved nasal spray actually feels like.
Find a Trusted Provider
Red flags to spot, credentials to verify, and the questions every patient should ask before booking.
Drug & Treatment Comparisons
Ketamine vs. antidepressants, TMS, ECT, psilocybin — and how IV, oral, and nasal delivery actually differ.
Safety & Interactions
Caffeine, cannabis, prescription med interactions, addiction risk, and contraindications — covered plainly.
Cost & Insurance
Real price ranges, insurance loopholes, and how to lower out-of-pocket cost without sacrificing safety.
Start Where You Are
Use this site to learn the basics, understand risks, compare options, and prepare for better care conversations.
Get oriented
Understand ketamine therapy options, who they may fit, and what questions matter early.
Check the details
Review safety, costs, provider models, treatment preparation, and route differences.
Plan the conversation
Use guides and tools to ask more specific questions before making treatment decisions.
Guides Worth Starting With
Longer explainers on safety, treatment options, providers, costs, and preparation.
Telehealth Ketamine Treatment: What You Need to Know
How at-home telehealth ketamine programs work end to end: video evaluation, screening, prescription, shipping, and how many days from intake to first dose at a reputable provider.
Caregiver's Guide to Supporting Someone Through Ketamine Therapy
How to support a partner, parent, or friend through ketamine therapy: what caregivers actually do before a session, monitoring during dosing, and the integration window where most people need help.
What to Do When Ketamine Therapy Stops Working
Ketamine losing its effect? Tolerance, dose adjustments, route switching, treatment breaks, and augmentation options to try when sessions stop helping.
Decision Tools
Use checklists and calculators to organize provider questions and next steps.
Ketamine Cost Estimator
Estimate common ketamine therapy cost ranges by route, region, session count, maintenance care, and insurance assumptions.
Candidate Discussion Screener
Organize clinician-facing questions about possible fit, cautions, contraindications, support needs, and next steps.
Provider Evaluation Checklist
Compare clinics and telehealth programs by credentials, screening, monitoring, emergency planning, transparency, and follow-up.
Session Preparation Checklist
Prepare for a ketamine appointment with timing-based reminders for transportation, medication review, fasting instructions, recovery time, and safety planning.
Explore Ketamine Topics
Safety, costs, providers, comparisons, research, and practical patient questions.
Guides
Comprehensive explainers on how ketamine therapy works, what to expect, and how to plan treatment.
Journeys
Patient-centered stories and real-world treatment paths to help you understand the experience.
Questions
Straight answers to the most common questions about safety, outcomes, logistics, and candidacy.
Providers
How to find and evaluate ketamine providers, compare care models, and avoid common red flags.
Comparisons
Clear side-by-side breakdowns of treatment options, delivery methods, costs, and tradeoffs.
News
Current research, regulatory updates, access changes, and market developments worth tracking.
Ketamine Briefs
Short, practical updates on ketamine research, access, safety, providers, and treatment decisions.
Cambridge Joins UK's Growing Psychedelic Research Push
Cambridge University has added its weight to UK psychedelic research. Here's what this institutional...
BriefNew PTSD Prevention Drug Trial Enrolls First Patients
A DoD-backed Phase 2a trial is testing BXCL501 for acute stress reactions and PTSD prevention. Here'...
BriefKetamine Therapy Cost and Insurance: Frequently Asked Questions
Common questions about the cost of ketamine therapy, insurance coverage, payment options, and how to...
BriefGetting Started with Ketamine Therapy: Frequently Asked Questions
Common questions and answers about starting ketamine therapy — who qualifies, how to begin, what the...
Compare your options before deciding
See route, setting, cost, and safety differences before your next provider conversation.
Where to start
Most readers come here at one of three points: deciding whether ketamine is a reasonable option, choosing between providers, or evaluating how a course is going. The guides, comparisons, and FAQ are organised to meet you wherever you are.
Browse by section
Featured
Recent news
Have a correction or a question?
We update content as evidence and clinical practice evolve.
Latest Ketamine Updates
Recent research, access, safety, policy, and provider-market updates.
How to Evaluate an At-Home Ketamine Provider: Patient Guide
Learn key questions to ask when comparing at-home ketamine providers. Patient-focused guide to safety protocols, credent...
2026 Psychedelic Policy Shifts: What Patients Should Know
A wave of state and federal psychedelic legislation in April 2026 could reshape the therapeutic landscape — here's what...
Ketamine Therapy for Couples: What the Research Shows
Can couples do ketamine therapy together? What 2026 clinical research shows about ketamine for marriage, relationship re...
FDA Clears Trial Pairing Ketamine Follow-Up Drug With TMS
The FDA cleared the MIND1 trial testing NRX-101 with robotic TMS for treatment-resistant depression and suicidality. Wha...
CBT After Esketamine Boosts Depression Outcomes in Trial
A new randomized trial finds that adding 16 weeks of CBT after esketamine significantly improves depression and suicidal...
FDA Clears NMDA Drug for Alzheimer's Agitation — What It Means for Ketamine Patients
The FDA approved Axsome's AXS-05 for Alzheimer's-related agitation. Here's what this NMDA antagonist approval means for...
Treatment Comparisons
Side-by-side breakdowns of route, cost, supervision, access, and evidence tradeoffs.
Ketamine vs Stellate Ganglion Block: Comparing Newer Mental Health Treatments
Ketamine therapy vs stellate ganglion block (SGB): how each works for PTSD and anxiety, side effects, cost, evidence, and which to consider first.
Read comparison →IV Ketamine vs At-Home Ketamine: Comparing Clinic and Home-Based Treatment
A detailed comparison of IV ketamine infusions at a clinic versus at-home ketamine therapy programs — covering effectiveness, cost, convenience, safety, and which option may suit you best.
Read comparison →Ketamine Plus Therapy vs Therapy Alone: Does Ketamine Enhance Talk Therapy?
Research on combining ketamine with psychotherapy versus ketamine alone: relapse rates, neuroplasticity windows, and which integration formats (KAP, CBT, structured) show the strongest depression outcomes.
Read comparison →Generic Ketamine vs Spravato: Comparing Off-Label and FDA-Approved Options
Side-by-side comparison of generic racemic ketamine and Spravato (esketamine) nasal spray: per-session cost, insurance coverage, FDA approval status, and what generic availability looks like in 2026.
Read comparison →Telehealth Ketamine vs In-Clinic Treatment: Which Approach Is Right for You?
A detailed comparison of telehealth ketamine programs and in-person clinic treatment — evaluating convenience, safety, cost, effectiveness, and the patient experience of each.
Read comparison →Oral vs Sublingual Ketamine: Tablets, Troches, and How They Compare
How oral ketamine tablets compare to sublingual troches for at-home therapy: bioavailability (around 20-30% sublingual vs 8-17% oral), onset time, side-effect profile, and which format suits which patient.
Read comparison →Better decisions start with better questions.
— Ketamine Path editorial guide
Important Disclaimer
Educational content only. Ketamine treatment decisions should be made with a licensed clinician. Seek emergency help for suicidal thoughts, chest pain, breathing problems, severe confusion, mania, psychosis, or other urgent symptoms.